Copyright
        ©The Author(s) 2020.
    
    
        World J Gastrointest Oncol. Oct 15, 2020; 12(10): 1133-1145
Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1133
Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1133
		Figure 1 Changes in surgical approaches for treating nonfunctioning-pancreatic neuroendocrine tumors over time.
		
			 MIS: Minimally invasive surgery.
		
	
		Figure 2 Comparison of disease-free survival rates between open pancreatic resection and minimally invasive approaches for treating patients with nonfunctioning pancreatic neuroendocrine tumors.
		
			 DFS: Disease-free survival; MIS: Minimally invasive surgery; NF-PNET: Nonfunctioning-pancreatic neuroendocrine tumors.
		
	
- Citation: Kim J, Hwang HK, Lee WJ, Kang CM. Minimally invasive vs open pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors. World J Gastrointest Oncol 2020; 12(10): 1133-1145
 - URL: https://www.wjgnet.com/1948-5204/full/v12/i10/1133.htm
 - DOI: https://dx.doi.org/10.4251/wjgo.v12.i10.1133
 
